Author Archives: Iqra Mumal, MSc

Inflammatory Conditions Linked to Higher Risk of Alzheimer’s

Patients with inflammatory diseases such as rheumatoid arthritis or psoriasis have a higher risk of developing Alzheimer’s disease, which can be reduced by treatment with tumor necrosis factor (TNF) inhibitors. That finding, “Tumor Necrosis Factor (TNF) Blocking Agents Reduce Risk for Alzheimer’s Disease in Patients with Rheumatoid…

New Strategy May Help Identify Those with Mild Cognitive Impairment at Risk to Develop Alzheimer’s

A newly developed strategy may help researchers identify which people with mild cognitive impairment are likely to develop Alzheimer’s disease. The study, “Utilizing Semantic Intrusions to Identify Amyloid Positivity in Mild Cognitive Impairment,” was published in the journal Neurology. There is a critical need to develop disease-modifying treatments for Alzheimer’s…

ProMIS’ PMN310 Shows Improved Safety Profile, Specificity Compared to Similar Alzheimer’s Candidates

ProMIS Neurosciences’ lead therapeutic candidate for Alzheimer’s disease, PMN310, showed an improved safety profile when directly compared to other amyloid-beta directed antibodies, according to preclinical study results. Unlike BAN2401 (Biogen, Eisai) and aducanumab (Biogen), two amyloid-beta directed antibodies both in clinical development, PMN310 did not…